Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Baldo

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|November 14, 2023
Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case ReportsSabrina Orzetti, Paolo Baldo
Oncotargets and Therapy|November 30, 2017
Amatuximab and novel agents targeting mesothelin for solid tumorsPaolo Baldo, Sara Cecco
Journal of Evaluation in Clinical Practice|June 10, 2014
Pharmacovigilance in oncology: evaluation of current practice and future perspectivesPaolo Baldo, Paolo De Paoli
Advances in Therapy|September 16, 2018
An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative ReviewGiulia Fornasier, Sara Francescon, Paolo Baldo
International Journal of Clinical Pharmacy|August 11, 2018
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminologyPaolo Baldo, Sara Francescon, Giulia Fornasier
Oncology and Therapy|March 7, 2017
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance ConsiderationsSara Francescon, Giulia Fornasier, Paolo Baldo
International Journal of Clinical Pharmacy|August 11, 2018
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodiesSara Francescon, Giulia Fornasier, Paolo Baldo
Expert Opinion on Therapeutic Targets|December 14, 2023
How will the identification and therapeutic intervention of genetic targets in oncology evolve for future therapy?Paolo Baldo, Valli De Re, Mattia Garutti
International Journal of Clinical Pharmacy|June 28, 2018
An historical overview over PharmacovigilanceGiulia Fornasier, Sara Francescon, Roberto Leone, et al.
International Journal of Clinical Pharmacy|August 3, 2018
Pharmacovigilance in oncologyPaolo Baldo, Giulia Fornasier, Laura Ciolfi, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|November 14, 2023
Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case ReportsSabrina Orzetti, Paolo Baldo
Oncotargets and Therapy|November 30, 2017
Amatuximab and novel agents targeting mesothelin for solid tumorsPaolo Baldo, Sara Cecco
Journal of Evaluation in Clinical Practice|June 10, 2014
Pharmacovigilance in oncology: evaluation of current practice and future perspectivesPaolo Baldo, Paolo De Paoli
Advances in Therapy|September 16, 2018
An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative ReviewGiulia Fornasier, Sara Francescon, Paolo Baldo
International Journal of Clinical Pharmacy|August 11, 2018
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminologyPaolo Baldo, Sara Francescon, Giulia Fornasier
Oncology and Therapy|March 7, 2017
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance ConsiderationsSara Francescon, Giulia Fornasier, Paolo Baldo
International Journal of Clinical Pharmacy|August 11, 2018
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodiesSara Francescon, Giulia Fornasier, Paolo Baldo
Expert Opinion on Therapeutic Targets|December 14, 2023
How will the identification and therapeutic intervention of genetic targets in oncology evolve for future therapy?Paolo Baldo, Valli De Re, Mattia Garutti
International Journal of Clinical Pharmacy|June 28, 2018
An historical overview over PharmacovigilanceGiulia Fornasier, Sara Francescon, Roberto Leone, et al.
International Journal of Clinical Pharmacy|August 3, 2018
Pharmacovigilance in oncologyPaolo Baldo, Giulia Fornasier, Laura Ciolfi, et al.
Pageof 4